Depression is a common mental disorder. Many patients do not respond to adequate sequential courses of treatment， clinically known as treatment-resistant depression. With further understanding of the mechanisms of depression， non-monoamine hypotheses offer a crucial new dimension for the development of fundamentally novel antidepressant treatments. This paper reviews a large number of studies on antidepressants based on glutamate， opioid and cholinergic systems have been carried out.